Glycative Stress and Its Defense Machinery Glyoxalase 1 in Renal Pathogenesis.

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
Sevelamer 1 nephrologydiseasesdrugs
chronic kidney disease 4 nephrologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
Sevelamer 20470 heat cooking methods (i.e., broiling) [[72]].AGE absorbents can promote the fecal excretion of AGEs. Sevelamer hydrochloride, a frequently used inorganic phosphate binder in dialysis patients, is reportedly able
Select Disease Character Offset Disease Term Instance
chronic kidney disease 943 glycated end products (AGEs) and their precursors such as reactive carbonyl compounds, exacerbates chronic kidney disease and is related to premature aging in chronic kidney disease, whether caused by diabetes mellitus or
chronic kidney disease 1003 reactive carbonyl compounds, exacerbates chronic kidney disease and is related to premature aging in chronic kidney disease , whether caused by diabetes mellitus or otherwise. Factors which hinder a sufficient reduction in glycative
chronic kidney disease 1366 (ER) stress and hypoxia in the kidney. Promising strategies aimed at halting the vicious cycle between chronic kidney disease and increases in glycative stress include the suppression of AGE accumulation in the body and the enhancement
chronic kidney disease 23538 accumulation constitutes a vicious cycle. Abbreviations: AGEs, advanced glycation end products; CKD, chronic kidney disease ; GLO-1, glyoxalase 1

You must be authorized to submit a review.